CL2011002637A1 - Compuestos derivados del acido bifenil-2-il-carbamico, agonista de receptores muscarinos y antagonista b2 adrenergicos; proceso de preparacion de estos; compuesto intermediario; composicion farmaceutica que lo comprende; y su uso en el tratamiento de enfermedades respiratorias. - Google Patents

Compuestos derivados del acido bifenil-2-il-carbamico, agonista de receptores muscarinos y antagonista b2 adrenergicos; proceso de preparacion de estos; compuesto intermediario; composicion farmaceutica que lo comprende; y su uso en el tratamiento de enfermedades respiratorias.

Info

Publication number
CL2011002637A1
CL2011002637A1 CL2011002637A CL2011002637A CL2011002637A1 CL 2011002637 A1 CL2011002637 A1 CL 2011002637A1 CL 2011002637 A CL2011002637 A CL 2011002637A CL 2011002637 A CL2011002637 A CL 2011002637A CL 2011002637 A1 CL2011002637 A1 CL 2011002637A1
Authority
CL
Chile
Prior art keywords
biphenyl
treatment
pharmaceutical composition
carbamic acid
agonist
Prior art date
Application number
CL2011002637A
Other languages
English (en)
Inventor
Adam Hughes
Daniel Chen Yan Fleury Melissa Jacobsen John R Stangeland Eric L Wilson Richard D Yen Rose Byun
Original Assignee
Theravance Respiratory Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42272140&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011002637(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theravance Respiratory Co Llc filed Critical Theravance Respiratory Co Llc
Publication of CL2011002637A1 publication Critical patent/CL2011002637A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Abstract

Compuestos derivados del ácido bifenil-2-il-carbamico; proceso de preparación; compuestos intermediarios; composición farmacéutica; y uso en el tratamiento de un trastorno pulmonar.
CL2011002637A 2009-04-23 2011-10-21 Compuestos derivados del acido bifenil-2-il-carbamico, agonista de receptores muscarinos y antagonista b2 adrenergicos; proceso de preparacion de estos; compuesto intermediario; composicion farmaceutica que lo comprende; y su uso en el tratamiento de enfermedades respiratorias. CL2011002637A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17203909P 2009-04-23 2009-04-23

Publications (1)

Publication Number Publication Date
CL2011002637A1 true CL2011002637A1 (es) 2012-04-27

Family

ID=42272140

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011002637A CL2011002637A1 (es) 2009-04-23 2011-10-21 Compuestos derivados del acido bifenil-2-il-carbamico, agonista de receptores muscarinos y antagonista b2 adrenergicos; proceso de preparacion de estos; compuesto intermediario; composicion farmaceutica que lo comprende; y su uso en el tratamiento de enfermedades respiratorias.

Country Status (32)

Country Link
US (14) US8138345B2 (es)
EP (3) EP3210981B1 (es)
JP (3) JP5671006B2 (es)
KR (1) KR101769061B1 (es)
CN (2) CN103936716B (es)
AR (1) AR076412A1 (es)
AU (1) AU2010239522B2 (es)
BR (1) BRPI1014877B8 (es)
CA (1) CA2758505C (es)
CL (1) CL2011002637A1 (es)
CO (1) CO6440584A2 (es)
CY (2) CY1119008T1 (es)
DK (3) DK2599778T3 (es)
ES (3) ES2635358T3 (es)
HK (1) HK1165799A1 (es)
HR (3) HRP20130468T1 (es)
HU (2) HUE035049T2 (es)
IL (1) IL215554A (es)
LT (2) LT2599778T (es)
MX (1) MX2011011156A (es)
MY (1) MY158339A (es)
NZ (1) NZ595850A (es)
PL (3) PL2599778T3 (es)
PT (3) PT2421849E (es)
RU (2) RU2543716C2 (es)
SG (1) SG175330A1 (es)
SI (3) SI2421849T1 (es)
SM (1) SMT201300060B (es)
TR (1) TR201903556T4 (es)
TW (2) TWI570115B (es)
WO (1) WO2010123766A1 (es)
ZA (1) ZA201107743B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY158339A (en) 2009-04-23 2016-09-30 Theravance Respiratory Co Llc DIAMIDE COMPOUNDS HAVING MUSCARING RECEPTOR ANTAGONIST AND ß2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
ITRM20110083U1 (it) 2010-05-13 2011-11-14 De La Cruz Jose Antonio Freire Piastra per la costruzione di carrelli per aeroplani
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
AR083115A1 (es) * 2010-09-30 2013-01-30 Theravance Inc Sales oxalato cristalinas de un compuesto diamida
KR101944564B1 (ko) 2011-06-10 2019-01-31 키에시 파르마슈티시 엣스. 피. 에이. 무스카린성 수용체 길항제 및 베타2 아드레날린성 수용체 효능제 활성을 가지는 화합물
CA2838777C (en) 2011-06-10 2019-04-30 Chiesi Farmaceutici S.P.A. Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
RU2661877C2 (ru) 2012-12-06 2018-07-20 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета-2-адренергических рецепторов
JP6421989B2 (ja) 2012-12-06 2018-11-14 チエシ ファルマスティスィ エス．ピー．エー． ムスカリン受容体アンタゴニストおよびβ２アドレナリン受容体アゴニスト活性を有する化合物
PE20151414A1 (es) 2012-12-18 2015-09-17 Almirall Sa NUEVOS DERIVADOS CARBAMATO DE CICLOHEXILO Y QUINUCLIDINILO QUE TIENEN ACTIVIDAD COMO AGONISTAS ß2 ADRENERGICOS Y COMO ANTAGONISTAS MUSCARINICOS M3
TWI643853B (zh) 2013-02-27 2018-12-11 阿爾米雷爾有限公司 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
TWI641373B (zh) 2013-07-25 2018-11-21 阿爾米雷爾有限公司 具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
TW201517906A (zh) 2013-07-25 2015-05-16 Almirall Sa 含有ｍａｂａ化合物和皮質類固醇之組合
CN104030933A (zh) * 2014-05-16 2014-09-10 烟台恒迪克能源科技有限公司 一种β-异烷醇基氨基戊酸环己胺的合成方法
TW201617343A (zh) 2014-09-26 2016-05-16 阿爾米雷爾有限公司 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物
TWI703138B (zh) 2015-02-12 2020-09-01 義大利商吉斯藥品公司 具有蕈毒鹼受體拮抗劑及β２腎上腺素受體促效劑活性之化合物
CN107074816B (zh) * 2015-03-27 2020-07-17 四川海思科制药有限公司 一种杂环衍生物及其制备方法和在医药上的用途
CN107108562B (zh) * 2015-05-14 2020-07-10 四川海思科制药有限公司 具有β2受体激动及M受体拮抗活性的含氮杂螺环衍生物及其在医药上的用途
TW201704211A (zh) * 2015-05-14 2017-02-01 Sichuan Haisco Pharmaceutical Co Ltd 具有β２受體激動及Ｍ受體拮抗活性的聯苯衍生物及其在醫藥上的用途
AR104828A1 (es) 2015-06-01 2017-08-16 Chiesi Farm Spa COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARÍNICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO
EP3383867B1 (en) 2015-12-03 2021-04-14 Chiesi Farmaceutici S.p.A. Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
BR112018015018A2 (pt) * 2016-01-22 2018-12-18 Sichuan Haisco Pharmaceutical Co Ltd derivado de amido azaciclo, método de preparação deste, e aplicação farmacêutica
WO2018011090A1 (en) 2016-07-13 2018-01-18 Chiesi Farmaceutici S.P.A. Hydroxyquinolinone compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
RU2722720C1 (ru) 2016-12-14 2020-06-03 Бейджинг Шоубай Фармасьютикэл Ко., Лтд. Класс бифункциональных соединений со структурой соли четвертичного аммония
EP3625232B1 (en) 2017-05-19 2021-06-23 Council of Scientific and Industrial Research Substituted methanopyrido [2, 1-a]isoindolones as machr modulators for treating various associated pathophysiological conditions and process for preparation thereof
US11484531B2 (en) 2018-08-30 2022-11-01 Theravance Biopharma R&D Ip, Llc Methods for treating chronic obstructive pulmonary disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
DE60021282T2 (de) * 1999-12-07 2006-05-18 Theravance, Inc., South San Francisco Carbamat-derivate als muscarin-rezeptor antonisten
UA73543C2 (uk) 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
AU2001275760B2 (en) 2000-08-05 2005-03-17 Glaxo Group Limited 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
EP1463396A1 (en) * 2001-12-04 2004-09-29 TOKYO R&D CO., LTD. Power supply
ES2351392T3 (es) * 2003-02-14 2011-02-03 Theravance Inc Derivados bifenilo que tienen actividad agonista de receptores beta2-adrenérgicos y actividad antagonista de receptores muscarínicos.
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
ES2289691T3 (es) 2004-01-22 2008-02-01 Pfizer, Inc. Derivados de sulfonamida para el tratamiento de enfermedades.
US7320990B2 (en) * 2004-02-13 2008-01-22 Theravance, Inc. Crystalline form of a biphenyl compound
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
WO2005092861A1 (en) 2004-03-11 2005-10-06 Pfizer Limited Quinolinone derivatives pharmaceutical compositions containing them and their use
US7307076B2 (en) 2004-05-13 2007-12-11 Boehringer Ingelheim International Gmbh Beta agonists for the treatment of respiratory diseases
EP1833822A2 (en) * 2004-08-16 2007-09-19 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TWI374883B (en) * 2004-08-16 2012-10-21 Theravance Inc Crystalline form of a biphenyl compound
EP1778626A1 (en) * 2004-08-16 2007-05-02 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
DK2007214T4 (da) 2006-02-08 2014-09-22 Fuji Oil Europe Spiselige produkter med lavt indhold af mættede og trans-umættede fedter
GB0602778D0 (en) * 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
TW200811105A (en) * 2006-04-25 2008-03-01 Theravance Inc Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200811104A (en) * 2006-04-25 2008-03-01 Theravance Inc Crystalline forms of a dimethylphenyl compound
WO2008096129A1 (en) 2007-02-07 2008-08-14 Argenta Discovery Ltd Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors
RU2539979C2 (ru) 2008-07-25 2015-01-27 Вайтаи Фармасьютиклз, Инк. Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
MY158339A (en) 2009-04-23 2016-09-30 Theravance Respiratory Co Llc DIAMIDE COMPOUNDS HAVING MUSCARING RECEPTOR ANTAGONIST AND ß2 ADRENERGIC RECEPTOR AGONIST ACTIVITY

Also Published As

Publication number Publication date
TW201546057A (zh) 2015-12-16
PL2421849T3 (pl) 2013-08-30
US20100273755A1 (en) 2010-10-28
SI3210981T1 (sl) 2019-05-31
US20200165223A1 (en) 2020-05-28
HRP20170960T1 (hr) 2017-09-22
EP2599778B1 (en) 2017-04-12
US8551978B2 (en) 2013-10-08
US8816088B2 (en) 2014-08-26
US9572802B2 (en) 2017-02-21
TR201903556T4 (tr) 2019-04-22
JP5965440B2 (ja) 2016-08-03
US9394275B2 (en) 2016-07-19
JP2015147807A (ja) 2015-08-20
BRPI1014877B1 (pt) 2020-11-10
WO2010123766A1 (en) 2010-10-28
US10358433B2 (en) 2019-07-23
DK2599778T3 (en) 2017-06-26
US20150274697A1 (en) 2015-10-01
US10836744B2 (en) 2020-11-17
MY158339A (en) 2016-09-30
US20170096412A1 (en) 2017-04-06
AU2010239522B2 (en) 2015-07-02
SI2421849T1 (sl) 2013-07-31
JP5671006B2 (ja) 2015-02-18
TWI513693B (zh) 2015-12-21
RU2015101032A (ru) 2015-06-27
RU2011147374A (ru) 2013-05-27
IL215554A (en) 2014-08-31
SG175330A1 (en) 2011-11-28
NZ595850A (en) 2013-05-31
IL215554A0 (en) 2011-12-29
KR20110138292A (ko) 2011-12-26
ES2635358T3 (es) 2017-10-03
TW201041866A (en) 2010-12-01
PL3210981T3 (pl) 2019-06-28
US20140323733A1 (en) 2014-10-30
BRPI1014877A2 (pt) 2016-04-12
US8138345B2 (en) 2012-03-20
CN103936716A (zh) 2014-07-23
DK3210981T3 (en) 2019-04-01
US9682957B2 (en) 2017-06-20
US20170226082A1 (en) 2017-08-10
SI2599778T1 (sl) 2017-08-31
KR101769061B1 (ko) 2017-08-17
CN102405218B (zh) 2014-06-04
BRPI1014877B8 (pt) 2021-05-25
CY1121601T1 (el) 2020-05-29
AR076412A1 (es) 2011-06-08
EP2421849B1 (en) 2013-04-03
HRP20190417T1 (hr) 2019-04-19
HRP20130468T1 (en) 2013-06-30
CO6440584A2 (es) 2012-05-15
US20190300504A1 (en) 2019-10-03
US10590107B2 (en) 2020-03-17
CA2758505C (en) 2017-03-07
EP3210981A1 (en) 2017-08-30
US20160361304A1 (en) 2016-12-15
US10138220B1 (en) 2018-11-27
US20130331364A1 (en) 2013-12-12
JP2014210816A (ja) 2014-11-13
US20130137665A1 (en) 2013-05-30
ES2715965T3 (es) 2019-06-07
MX2011011156A (es) 2011-11-04
EP2599778A1 (en) 2013-06-05
ZA201107743B (en) 2012-06-27
PT3210981T (pt) 2019-04-01
CY1119008T1 (el) 2018-01-10
HUE042975T2 (hu) 2019-07-29
US9000173B2 (en) 2015-04-07
EP3210981B1 (en) 2019-01-02
JP2012524783A (ja) 2012-10-18
LT3210981T (lt) 2019-04-10
LT2599778T (lt) 2017-08-25
CN102405218A (zh) 2012-04-04
ES2417339T3 (es) 2013-08-07
US20210024493A1 (en) 2021-01-28
US9975875B2 (en) 2018-05-22
EP2421849A1 (en) 2012-02-29
HK1165799A1 (en) 2012-10-12
US20170362200A1 (en) 2017-12-21
TWI570115B (zh) 2017-02-11
SMT201300060B (it) 2013-07-09
PT2599778T (pt) 2017-06-06
CA2758505A1 (en) 2010-10-28
PT2421849E (pt) 2013-05-27
US20190047984A1 (en) 2019-02-14
DK2421849T3 (da) 2013-07-01
BRPI1014877A8 (pt) 2018-03-13
CN103936716B (zh) 2016-09-07
RU2015101032A3 (es) 2018-07-30
RU2543716C2 (ru) 2015-03-10
HUE035049T2 (en) 2018-05-02
PL2599778T3 (pl) 2018-01-31
RU2676686C2 (ru) 2019-01-10
AU2010239522A1 (en) 2011-11-10
US9771350B2 (en) 2017-09-26

Similar Documents

Publication Publication Date Title
CL2011002637A1 (es) Compuestos derivados del acido bifenil-2-il-carbamico, agonista de receptores muscarinos y antagonista b2 adrenergicos; proceso de preparacion de estos; compuesto intermediario; composicion farmaceutica que lo comprende; y su uso en el tratamiento de enfermedades respiratorias.
CY1117696T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΚΥΚΛΟΕΞΥΛΑΜΙΝΗΣ ΜΕ ΔΡΑΣΕΙΣ β2 ΑΔΡΕΝΕΡΓΙΚΟΥ ΑΓΩΝΙΣΤΗ ΚΑΙ Μ3 ΜΟΥΣΚΑΡΙΝΙΚΟΥ ΑΝΤΑΓΩΝΙΣΤΗ
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
CR20150296A (es) Novedosos derivados de bencimidazol como antagonistas de ep4
EA201270467A1 (ru) Полициклические соединения в качестве антагонистов рецепторов лизофосфатидной кислоты
MA32907B1 (fr) Régime posologique d'un agoniste du récepteur s1p
UY35391A (es) Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-cianometil)-amidas sustituidas inhibidores de catepsina c
EA201390821A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты и их применение
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201201541A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛАМИНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К M3 МУСКАРИНОВОМУ РЕЦЕПТОРУ
CL2015003290A1 (es) Nuevos agonistas del receptor de somatostatina subtipo 4 (sstr4).
EA201100133A1 (ru) Антагонисты рецепторов простагландина d
ECSP10010439A (es) Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina
EA201690033A3 (ru) Морфинановые соединения
ECSP088989A (es) (aza)ciclohexanos carboxilados nuevos como ligandos de receptores de dopamina d3
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
EA201300388A1 (ru) Соединения замещенного бензамида
CL2011002103A1 (es) Compuestos derivados de indazol; procedimiento de preparacion; compuesto intermediario; composicion farmaceutica y combinacion que los comprende; y uso para tratar una afeccion para la que esta indicado un antagonista del receptor ccr4.
MX2011012993A (es) Bencimidazoles, benzotiazoles y benzoxazoles, sustituidos.
EA201500651A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛ- И ХИНУКЛИДИНИЛКАРБАМАТА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3
EA201400623A1 (ru) Новые 2h-индазолы в качестве антагонистов рецептора ep
DOP2010000389A (es) Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos b2 para el tratamiento de trastornos respiratorios
PH12014502876A1 (en) Pharmaceutical composition containing fimasartan and hydrochlorothiazide
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique